REGN — Regeneron Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Regeneron Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,587	5,695	7,742	10,845	9,013
Net Total Accounts Receivable
Net Total Receivables	4,115	6,037	5,329	5,667	6,212
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,779	14,015	15,884	19,479	18,661
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,222	3,482	3,763	4,224	4,817
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	17,163	25,435	29,215	33,080	37,759
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,697	3,933	3,141	3,423	3,944
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6,138	6,666	6,551	7,107	8,406
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	11,025	18,769	22,664	25,973	29,354
Total Liabilities & Shareholders' Equity	17,163	25,435	29,215	33,080	37,759
Total Common Shares Outstanding